DS8-14999-27528
2 vaccinations
8 coded responses
23 check-ins
8 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 121 / NY
- Registered
- 2021-01-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Dose 1 — Pfizer-BioNTech
-
2021-01-23
Registered in v-safe
-
2021-01-23
Survey response — days 1–6 daily, dose 1MedDRA: Feeling abnormal, Headache, Self-medication — Feeling: Good · Site: Pain · Joint painsFree text: 6 hours post vaccine had mild headache with brain fog - headache resolved with pain reliever; brain fog persisted approximately 36 hoursMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-02-05
-
2021-02-11
Dose 2 — Pfizer-BioNTech
- 2021-02-11
-
2021-02-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Chills, Joint pains, Fatigue or tirednessAdult check-in
-
2021-02-14
Survey response — days 1–6 daily, dose 2MedDRA: Tenderness — Feeling: Fair · Site: Pain · Be unable to do your normal daily activitiesFree text: Constant tenderness over left templeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-15
Survey response — days 1–6 daily, dose 2MedDRA: Headache, Hypoaesthesia, Hypoaesthesia eye — Feeling: Fair · Site: Pain · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Pain left temple, superficial numbness on left side of face - cheek and around eyeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-15
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-16
Survey response — days 1–6 daily, dose 2MedDRA: Headache, Hypoaesthesia — Feeling: Good · Site: Pain · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Temple pain and facial numbness are resolving with Providers recommendationsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-17
- 2021-02-18
-
2021-02-25
Survey response — day 14, dose 2MedDRA: Laboratory test abnormal, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Thyroid testing resulted as abnormal - tested as a result of symptom onset 3 days post vaccine. · Healthcare visit (other): Laboratory drawMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-25
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-04
- 2021-03-11
-
2021-03-18
Survey response — day 35, dose 2MedDRA: Hypoaesthesia — Feeling: GoodFree text: Facial numbness which varies in severity, ongoing, intermittent discussion with MD - essentially awaiting resolution.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Survey response — day 42, dose 2MedDRA: Hypoaesthesia, Thyroid disorder — Feeling: GoodFree text: Intermittent facial numbness continues to be an issue. Awaiting followup lab work for thyroid issuesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-13
- 2021-08-04
- 2021-08-12
-
2022-02-11
Survey response — 12 months, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: GoodFree text: Slight exacerbation of facial numbness after booster. Mild numbness has been persistent but better.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Pfizer-BioNTech | |
| 2 | 2021-02-11 | Pfizer-BioNTech |
Call center
3 call center cases
3 unsuccessful
1 wait over 3 months for a first call
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): 6 hours post vaccine had mild headache with brain fog - headache resolved with pain reliever; brain fog persisted approximately 36 hours
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Constant tenderness over left temple
Systemic reaction (other): Pain left temple, superficial numbness on left side of face - cheek and around eye
Systemic reaction (other): Temple pain and facial numbness are resolving with Providers recommendations
Release 4 — day 14, dose 2
Symptoms: Thyroid testing resulted as abnormal - tested as a result of symptom onset 3 days post vaccine.
Healthcare visit (other): Laboratory draw
Release 5 — day 35, dose 2
Symptoms: Facial numbness which varies in severity, ongoing, intermittent discussion with MD - essentially awaiting resolution.
Release 6 — day 42, dose 2
Symptoms: Intermittent facial numbness continues to be an issue. Awaiting followup lab work for thyroid issues
Release 11 — 12 months, dose 2
Symptoms: Slight exacerbation of facial numbness after booster. Mild numbness has been persistent but better.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Hypoaesthesia | ✓ | ✓ | ✓ |
| SD | Laboratory test abnormal | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Thyroid disorder | ✓ | ✓ | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Hypoaesthesia eye | ✓ | ✓ | ✓ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
| SRO | Tenderness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release